Literature DB >> 15799822

The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice.

Hagit Dafni1, Batya Cohen, Keren Ziv, Tomer Israely, Orit Goldshmidt, Nava Nevo, Alon Harmelin, Israel Vlodavsky, Michal Neeman.   

Abstract

Heparanase expression has been linked to increased tumor invasion, metastasis, and angiogenesis and with poor prognosis. The aim of the study was to monitor the effect of heparanase expression on lymph node metastasis, in heparanase-overexpressing subcutaneous Eb mouse T-lymphoma tumors, and their draining lymph node. Dynamic contrast-enhanced magnetic resonance imaging (MRI) using biotin-BSA-GdDTPA-FAM/ROX was applied for analysis of blood volume, vascular permeability, and interstitial convection, and for detection of very early stages of such metastatic dissemination. Eb tumors increased extravasation, interstitial convection, and lymphatic drain of the contrast material. Interstitial flow directions were mapped by showing radial outflow interrupted in some tumors by directional flow toward the popliteal lymph node. Heparanase expression significantly increased contrast enhancement of the popliteal lymph node but not of the primary tumor. Changes in MR contrast enhancement preceded the formation of pathologically detectable metastases, and were detectable when only a few enhanced green fluorescent protein (EGFP)-expressing Eb cells were found near and within the nodes. These results demonstrate very early, heparanase-dependent vascular changes in lymph nodes that were visible by MRI following administration of biotin-BSA-GdDTPA-FAM/ROX, and can be used for studying the initial stages of lymph node infiltration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799822      PMCID: PMC1501142          DOI: 10.1593/neo.04433

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  37 in total

1.  Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: assessment in rabbits.

Authors:  S G Ruehm; C Corot; J F Debatin
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

2.  Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence.

Authors:  O Goldshmidt; E Zcharia; H Aingorn; Z Guatta-Rangini; R Atzmon; I Michal; I Pecker; E Mitrani; I Vlodavsky
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

3.  Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.

Authors:  C D Pham; T P Roberts; N van Bruggen; O Melnyk; J Mann; N Ferrara; R L Cohen; R C Brasch
Journal:  Cancer Invest       Date:  1998       Impact factor: 2.176

Review 4.  Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer.

Authors:  Y Anzai; M R Prince
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

5.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

6.  Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.

Authors:  M D Ogan; U Schmiedl; M E Moseley; W Grodd; H Paajanen; R C Brasch
Journal:  Invest Radiol       Date:  1987-08       Impact factor: 6.016

7.  Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique.

Authors:  D M Shames; R Kuwatsuru; V Vexler; A Mühler; R C Brasch
Journal:  Magn Reson Med       Date:  1993-05       Impact factor: 4.668

8.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Authors:  S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

9.  Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction.

Authors:  M Saeed; C F van Dijke; J S Mann; M F Wendland; W Rosenau; C B Higgins; R C Brasch
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

10.  Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.

Authors:  C F van Dijke; R C Brasch; T P Roberts; N Weidner; A Mathur; D M Shames; J S Mann; F Demsar; P Lang; H C Schwickert
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

View more
  10 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging.

Authors:  Hisataka Kobayashi; Yoshinori Koyama; Tristan Barrett; Yukihiro Hama; Celeste A S Regino; In Soo Shin; Beom-Su Jang; Nhat Le; Chang H Paik; Peter L Choyke; Yasuteru Urano
Journal:  ACS Nano       Date:  2007-11       Impact factor: 15.881

Review 3.  Perspectives: MRI of angiogenesis.

Authors:  Michal Neeman
Journal:  J Magn Reson       Date:  2018-04-12       Impact factor: 2.229

4.  Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.

Authors:  Yanan Song; Bin Hu; Hongjie Qu; Lu Wang; Yunxiao Zhang; Jinchao Tao; Jinquan Cui
Journal:  Oncotarget       Date:  2016-06-14

5.  Significance of heparanase in metastatic lymph nodes of cervical squamous cell cancer.

Authors:  Bin Hu; Qing Wang; Yingying Shi; Shufang Lu; Hongjie Qu; Lu Wang; Jinquan Cui
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

Review 6.  Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis.

Authors:  Reut Avni; Batya Cohen; Michal Neeman
Journal:  NMR Biomed       Date:  2011-01-17       Impact factor: 4.044

Review 7.  Visualizing vascular permeability and lymphatic drainage using labeled serum albumin.

Authors:  Katrien Vandoorne; Yoseph Addadi; Michal Neeman
Journal:  Angiogenesis       Date:  2010-05-29       Impact factor: 9.596

8.  Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation.

Authors:  Hagit Dafni; Sun-Jin Kim; James A Bankson; Madhuri Sankaranarayanapillai; Sabrina M Ronen
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

Review 9.  Dendrimers in medical nanotechnology.

Authors:  Tristan Barrett; Gregory Ravizzini; Peter L Choyke; Hisataka Kobayashi
Journal:  IEEE Eng Med Biol Mag       Date:  2009 Jan-Feb

10.  Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75.

Authors:  Batya Cohen; Yoseph Addadi; Stav Sapoznik; Gila Meir; Vyacheslav Kalchenko; Alon Harmelin; Shifra Ben-Dor; Michal Neeman
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.